Oklahoma Oncology, Inc. is a clinical research site located in Tulsa, Oklahoma, United States 74104.
Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.
Oklahoma Oncology, Inc. has participated in 2 clinical trials.
Therapeutic areas: Melanoma, Colorectal Neoplasms, Colonic Neoplasms.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Oklahoma Oncology, Inc. has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Oklahoma Oncology, Inc. has 2 clinical trials on record. Their work covers Melanoma, Colorectal Neoplasms, Colonic Neoplasms.
Oklahoma Oncology, Inc. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.